Geniebiome collaborates with CUHK on clinical trial to study the impact of a microbiome immunity formula SIM02 in the reduction of vaccine-related adverse reactions and improvement of COVID-19 vaccine efficacy.
MAR 2021
Study aims to evaluate in elderlies and patients with type 2 diabetes, the impact of G-NiiB Immunity Pro (SIM02) in reduction of vaccine-related adverse reactions and improvement of COVID-19 vaccine efficacy
CUHK study has been featured in DAILY MAIL UK, "Can looking in the loo help your health... or is it just potty? Scientists say checking before flushing can provide vital clues to your wellbeing.
GenieBiome collaborates with CUHK on clinical trial to study the impact of a microbiome immunity formula SIM02 in the reduction of vaccine-related adverse reaction and improvement of COVID-19 vaccine efficacy.
